galantamine has been researched along with Atrioventricular Conduction Block in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berkers, M; Carmichael, PH; Egberts, T; Kröger, E; Souverein, P; van Marum, R | 1 |
1 other study(ies) available for galantamine and Atrioventricular Conduction Block
Article | Year |
---|---|
Use of rivastigmine or galantamine and risk of adverse cardiac events: a database study from the Netherlands.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrioventricular Block; Cholinesterase Inhibitors; Cohort Studies; Cross-Over Studies; Databases, Factual; Female; Galantamine; Hospitalization; Humans; Incidence; Male; Netherlands; Phenylcarbamates; Poisson Distribution; Proportional Hazards Models; Risk; Rivastigmine; Syncope | 2012 |